Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 11/20 | 0.61 |
| ▸ | F13A1 | P00488 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | TGM1 | P22735 | 1/20 | 0.49 |
| ▸ | TGM3 | Q08188 | 1/20 | 0.49 |
| ▸ | EGFR | P00533 | 2/20 | 0.39 |
| ▸ | JAK3 | P52333 | 1/20 | 0.39 |
| ▸ | MAP2K7 | O14733 | 1/20 | 0.39 |
| ▸ | AURKA | O14965 | 1/20 | 0.39 |
| ▸ | THRA | P10827 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | FYN | P06241 | 1/20 | 0.38 |
| ▸ | SRC | P12931 | 1/20 | 0.38 |
| ▸ | ITK | Q08881 | 1/20 | 0.38 |
| ▸ | BTK | Q06187 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26696846 | 0.86 | IRAK1 (0.53) | TGM2BTK | |
| SCHEMBL16370465 | 0.79 | LPAR2 (0.62) | LMNATHRB | |
| SCHEMBL16370394 | 0.79 | LPAR2 (0.62) | LMNATHRB | |
| SCHEMBL6611347 | 0.79 | MTNR1A (0.43) | TGM2LMNAEGFR | |
| SCHEMBL6611344 | 0.79 | MTNR1A (0.43) | TGM2LMNAEGFR | |
| SCHEMBL168530 | 0.77 | TGM2 (0.64) | TGM2F13A1LMNATGM1TGM3 | |
| SCHEMBL2531539 | 0.77 | EPHX2 (0.41) | TGM2 | |
| SCHEMBL81209 | 0.77 | TGM2 (1.00) | TGM2F13A1LMNATGM1TGM3 | |
| SCHEMBL28043926 | 0.76 | TGM2 (0.32) | TGM2 | |
| SCHEMBL900234 | 0.76 | NAMPT (0.48) | EGFRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118311119-A | Method for detecting two cancer markers without marks based on chronopotentiometric nanopore sensor | 中国科学院烟台海岸带研究所 | 2024-07-09 | — | — | CN | claimed |
| US-11897891-B2 | Tricyclic heterocycles as FGFR inhibitors | INCYTE CORPORATION (US) | 2024-02-13 | — | — | US | claimed |
| WO-2022012550-A1 | SUBSTITUTED 1H-IMIDAZO [1, 2-B] PYRAZOLE-3-CARBOXAMIDE AS BRUTON'S TYROSINE KINASE INHIBITORS | HENAN NORMAL UNIVERSITY (CN) | 2022-01-20 | — | — | WO | claimed |
| WO-2021113479-A1 | TRICYCLIC HETEROCYCLES AS FGFR INHIBITORS | INCYTE CORPORATION (US) | 2021-06-10 | — | — | WO | claimed |
| US-20210171535-A1 | TRICYCLIC HETEROCYCLES AS FGFR INHIBITORS | INCYTE CORPORATION | 2021-06-10 | — | — | US | claimed |
| EP-3802510-A1 | MONOETHYLENICALLY UNSATURATED MONOMERS AND USES THEREOF | Bostik SA (FR) | 2021-04-14 | — | — | EP | claimed |
| CN-110498886-A | A kind of lubricating hydrogel material and its preparation method and application | UNIV JILIN | 2019-11-26 | — | — | CN | claimed |
| CN-110470717-A | A kind of preparation method of the screen printing electrode of composite nano materials modification | UNIV JIANGNAN | 2019-11-19 | — | — | CN | claimed |
| CN-110273182-A | A kind of three-dimensional counter opal polymer photon crystal material and its preparation method and application | 郑州大学 | 2019-09-24 | — | — | CN | claimed |
| CN-110183574-A | A kind of application of phenyl boric acid based polyalcohol carrier and its selective absorption glucide | 苏州福赛思生物科技有限公司 | 2019-08-30 | — | — | CN | claimed |
| EP-1527105-B1 | SYNTHESIS OF STATISTICAL MICROGELS BY MEANS OF CONTROLLED RADICAL POLYMERISATION | RHODIA CHIMIE SA (FR) | 2009-02-25 | — | — | EP | claimed |
| WO-2008150118-A2 | NOVEL AMIDE DERIVATIVE FOR INHIBITING THE GROWTH OF CANCER CELLS | HANMI PHARM. CO., LTD. (KR) | 2008-12-11 | — | — | WO | claimed |
| EP-1765895-A1 | SYNTHESIS OF COPOLYMERS IN THE FORM OF A MIKTO STAR BY CONTROLLED RADICAL POLYMERIZATION | RHODIA CHIMIE (FR) | 2007-03-28 | — | — | EP | claimed |
| EP-1675880-A1 | METHOD FOR PARTIAL OR TOTAL OXIDATION OF ONE OR SEVERAL THIOCARBONYLTHIO ENDS OF A POLYMER OBTAINED BY RADICAL POLYMERISATION CONTROLLED BY REVERSIBLE ADDITION-CLEAVAGE | RHODIA CHIMIE (FR) | 2006-07-05 | — | — | EP | claimed |
| WO-2005116097-A1 | SYNTHESIS OF COPOLYMERS IN THE FORM OF A MIKTO STAR BY CONTROLLED RADICAL POLYMERIZATION | RHODIA CHIMIE (FR) | 2005-12-08 | — | — | WO | claimed |
| WO-2005040233-A1 | METHOD FOR PARTIAL OR TOTAL OXIDATION OF ONE OR SEVERAL THIOCARBONYLTHIO ENDS OF A POLYMER OBTAINED BY RADICAL POLYMERISATION CONTROLLED BY REVERSIBLE ADDITION-CLEAVAGE | RHODIA CHIMIE (FR) | 2005-05-06 | — | — | WO | claimed |
| EP-1527105-A2 | SYNTHESIS OF STATISTICAL MICROGELS BY MEANS OF CONTROLLED RADICAL POLYMERISATION | RHODIA CHIMIE (FR) | 2005-05-04 | — | — | EP | claimed |
| EP-1504039-A1 | POLYMER OBTAINED BY MEANS OF CONTROLLED RADICAL POLYMERISATION COMPRISING AT LEAST ONE BORONATE FUNCTION, ASSOCIATION THEREOF WITH A LIGAND COMPOUND AND USES OF SAME | RHODIA CHIMIE (FR) | 2005-02-09 | — | — | EP | claimed |
| WO-2004014535-A2 | SYNTHESIS OF STATISTICAL MICROGELS BY MEANS OF CONTROLLED RADICAL POLYMERISATION | RHODIA CHIMIE (FR) | 2004-02-19 | — | — | WO | claimed |
| WO-2003095502-A1 | POLYMER OBTAINED BY MEANS OF CONTROLLED RADICAL POLYMERISATION COMPRISING AT LEAST ONE BORONATE FUNCTION, ASSOCIATION THEREOF WITH A LIGAND COMPOUND AND USES OF SAME | RHODIA CHIMIE (FR) | 2003-11-20 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11897891-B2 | Tricyclic heterocycles as FGFR inhibitors | FGFR3, FGFR1, FGFR2 | TGM2 175/4885F13A1 2860/4885LMNA 4496/4885 |
| US-20210171535-A1 | TRICYCLIC HETEROCYCLES AS FGFR INHIBITORS | FGFR3, FGFR1, FGFR2 | TGM2 175/4885F13A1 2860/4885LMNA 4496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.